Epidemiology of prostate cancerCRAWFORD, E. David.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6A, pp 3-12, issn 0090-4295, 10 p.Conference Paper

Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia : the central role of the patient risk profileCRAWFORD, E. David.BJU international. Supplement (Print). 2005, Vol 95, Num 4, pp 1-5, issn 1465-5101, 5 p.Article

Use of algorithms as determinants for individual patient decision making: National comprehensive cancer network versus artificial neural networksCRAWFORD, E. David.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6A, pp 13-19, issn 0090-4295, 7 p.Conference Paper

Practical issues facing urologists in the treatment of prostate cancer: Opportunities and challenges with the current standard of careCRAWFORD, E. David.Urology (Ridgewood, NJ). 2003, Vol 62, Num 6A, issn 0090-4295, 44 p.Conference Proceedings

LUTS/BPH management: the central role of the patient risk profileCRAWFORD, E. David.BJU international. Supplement (Print). 2005, Vol 95, Num 4, issn 1465-5101, 39 p.Serial Issue

Adapting your practice in the wake of medicare reform: a look at luteinizing hormone-releasing hormone agonist therapyCRAWFORD, E. David.Urology (Ridgewood, NJ). 2004, Vol 64, Num 5A, issn 0090-4295, 20 p., SUPConference Proceedings

Patient selection for therapy in prostate cancerCRAWFORD, E. David.European urology. Supplement. 2002, Vol 1, Num 2, pp 2-6, issn 1569-9056, 5 p.Article

The role of the urologist in chemotherapy of hormone refractory prostate cancerCRAWFORD, E. David.Urology (Ridgewood, NJ). 1999, Vol 54, Num 6A, issn 0090-4295, 54 p.Serial Issue

The role of hormonal therapy in thetreatment of locally advanced prostate cancer-regional perspectives: USACRAWFORD, E. David.European urology. Supplement. 2004, Vol 3, Num 1, pp 17-21, issn 1569-9056, 5 p.Conference Paper

Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progressionTRACHTENBERG, John.BJU international. Supplement (Print). 2005, Vol 95, Num 4, pp 6-11, issn 1465-5101, 6 p.Article

The management of high risk prostate cancerAKDUMAN, Bulent; CRAWFORD, E. David.The Journal of urology. 2003, Vol 169, Num 6, pp 1993-1998, issn 0022-5347, 6 p.Article

Should routine screening for prostate-specific antigen be recommended? RebuttalOOTTAMASATHIEN, Siam; CRAWFORD, E. David.Archives of internal medicine (1960). 2003, Vol 163, Num 6, pp 661-662, issn 0003-9926, 4 p.Article

Current Topics in UrologyCRAWFORD, E. David; MARBERGER, Michael.Urology (Ridgewood, NJ). 1999, Vol 53, Num 3A, issn 0090-4295, 44 p., SUPConference Proceedings

The PCPT : New findings, new insights, and clinical implications for the prevention of prostate cancerAKDUMAN, Bulent; CRAWFORD, E. David.European urology. Supplement. 2006, Vol 5, Num 9, pp 634-639, issn 1569-9056, 6 p.Article

Lower urinary tract symptoms suggestive of benign prostatic hyperplasia : latest update on α₁-adrenoceptor antaqonistsMILANI, Shirin; DJAVAN, Bob.BJU international. Supplement (Print). 2005, Vol 95, Num 4, pp 29-36, issn 1465-5101, 8 p.Article

Medicare reform and your practice: What you need to knowLYNE, John Christopher.Urology (Ridgewood, NJ). 2004, Vol 64, Num 5A, pp 2-7, issn 0090-4295, 6 p., SUPConference Paper

Practice management and patient care: Is there an ideal situation for both patients and physician practices in light of legislative reform?SCIONTI, Stephen M.Urology (Ridgewood, NJ). 2004, Vol 64, Num 5A, pp 8-14, issn 0090-4295, 7 p., SUPConference Paper

Early versus late hormonal therapy: Debating the issuesCRAWFORD, E. David.Urology (Ridgewood, NJ). 2003, Vol 61, Num 2A, pp 8-13, issn 0090-4295, 6 p.Article

Innovative approaches to the hormonal treatment of advanced prostate cancerTRACHTENBERG, J.European urology. 1997, Vol 32, pp 78-80, issn 0302-2838, SUP3Conference Paper

Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate CancerCRAWFORD, E. David.Urology (Ridgewood, NJ). 2009, Vol 73, Num 5A, pp 4-10, issn 0090-4295, 7 p., SUPArticle

Hormonal Management of Prostate Cancer: Current Status and Future Developments, June 2003, Los Angeles, CA, USACRAWFORD, E. David; BONO, Aldo V.European urology. Supplement. 2004, Vol 3, Num 1, issn 1569-9056, 42 p.Conference Proceedings

Anti-androgens and other hormonal therapies for prostate cancerRICHIE, J. P.Urology (Ridgewood, NJ). 1999, Vol 54, Num 6A, pp 15-18, issn 0090-4295Article

Review of phase II hormone refractory prostate cancer trialsMURPHY, G. P.Urology (Ridgewood, NJ). 1999, Vol 54, Num 6A, pp 19-21, issn 0090-4295Article

Chemotherapy for advanced hormone refractory prostate cancerPETRYLAK, D. P.Urology (Ridgewood, NJ). 1999, Vol 54, Num 6A, pp 30-35, issn 0090-4295Article

Management of Prostate Cancer. European-American Encounter, International SymposiumSCHULMAN, Claude C; CRAWFORD, E. David.European urology. 1997, Vol 32, issn 0302-2838, 91 p., SUP3Conference Proceedings